Novo Nordisk logo – manufacturer of Ozempic, Wegovy, Rybelsus, Victoza, and Novorapid insulin for diabetes and obesity management

Novo Nordisk logo – manufacturer of Ozempic, Wegovy, Rybelsus, Victoza, and Novorapid insulin for diabetes and obesity management
NOVO NORDISK

Novo Nordisk is a world-leading healthcare company specializing in diabetes care, obesity management, and hormone therapy. Its portfolio includes globally recognized GLP-1 receptor agonists such as Ozempic®, Wegovy®, and Rybelsus®, all based on Semaglutide, as well as Victoza® (Liraglutide) and Novorapid® (Insulin Aspart). Novo Nordisk is renowned for pioneering weight loss injections and innovative insulin delivery systems like NovoPen®, making it a trusted name in metabolic and endocrine health worldwide.
14 products, 14 shown